JP2007097884A - Formation method of dna/chitosan complex - Google Patents

Formation method of dna/chitosan complex Download PDF

Info

Publication number
JP2007097884A
JP2007097884A JP2005292630A JP2005292630A JP2007097884A JP 2007097884 A JP2007097884 A JP 2007097884A JP 2005292630 A JP2005292630 A JP 2005292630A JP 2005292630 A JP2005292630 A JP 2005292630A JP 2007097884 A JP2007097884 A JP 2007097884A
Authority
JP
Japan
Prior art keywords
dna
chitosan
chitosan complex
mold
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005292630A
Other languages
Japanese (ja)
Other versions
JP4354445B2 (en
Inventor
Shigeo Okahata
恵雄 岡畑
Tadao Fukushima
忠男 福島
Minoru Kawaguchi
稔 川口
Kazuya Nishimura
和也 西村
Harutomo Sekido
治知 関戸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nichiro Corp
Original Assignee
Nichiro Corp
Nichiro Gyogyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nichiro Corp, Nichiro Gyogyo Kaisha Ltd filed Critical Nichiro Corp
Priority to JP2005292630A priority Critical patent/JP4354445B2/en
Publication of JP2007097884A publication Critical patent/JP2007097884A/en
Application granted granted Critical
Publication of JP4354445B2 publication Critical patent/JP4354445B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an easy formation method of a DNA/chitosan complex capable of using DNA for various types of applications while stably retaining the characteristics of DNA. <P>SOLUTION: Buffer solution is made to act on DNA/chitosan complex to provide it with formability and form the DNA/chitosan complex into an intended shape. It is preferable in this method that the DNA/chitosan complex is acquired as sediment by reacting DNA with chitosan in aqueous medium. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明はDNA/キトサン複合体の成形方法に関する。   The present invention relates to a method for forming a DNA / chitosan complex.

近年、DNAは新規機能材料として注目されている。それはDNAが構造上安定な規則正しい二重らせん(二本鎖)構造をとることに起因している。二重らせん構造を保持したDNAは天然由来の素材であるとともに、電気を通しやすく、また、二重らせん構造中に、色素などの各種化合物を取り込む性質が知られている。このようなことから、DNAは医療用素材、導電性素材、記録素子(CD−RやDVDなど)、有機EL素子など様々な用途での利用が期待されている。   In recent years, DNA has attracted attention as a novel functional material. This is due to the fact that DNA has a regular double helix (double stranded) structure that is structurally stable. DNA having a double helix structure is a naturally-derived material, and is easy to conduct electricity, and has a property of incorporating various compounds such as dyes into the double helix structure. For these reasons, DNA is expected to be used in various applications such as medical materials, conductive materials, recording elements (CD-R, DVD, etc.), organic EL elements, and the like.

その反面、サケ白子等の原材料から二重らせん構造を破壊せずに分離精製したDNAは水溶性であり、そのままの形態で上記用途への適用を考えた場合に安定性を欠くという大きな問題を有している。そのため、ポリアニオンとしてのDNAと、ポリアニオンに静電的に結合するポリカチオンである合成脂質等との複合化による安定化が図られている(特開2001−327591号公報)。   On the other hand, DNA that has been separated and purified from raw materials such as salmon shiroko without destroying the double helix structure is water-soluble and has a major problem that it lacks stability when applied to the above-mentioned uses in its original form. Have. For this reason, stabilization by conjugation of DNA as a polyanion with a synthetic lipid or the like which is a polycation that electrostatically binds to the polyanion has been attempted (Japanese Patent Laid-Open No. 2001-327591).

このようなDNAの安定化ための方法の一つとして、特開平10−77235号公報にはDNAをキトサンとの複合体として安定化させる方法が開示されている。また、特開2001−199903号公報には遺伝子分野の治療に好適と考えられる核酸とキトサンとの複合体の記載がある。また、特開2001−500109号公報には、上皮細胞への遺伝子の送達に適当な組成物として、キトサンと核酸の粒状複合体を含んでなる組成物が開示されている。
特開2001−327591号公報 特開平10−77235号公報 特開2001−199903号公報 特開2001−500109号公報
As one of the methods for stabilizing such DNA, JP-A-10-77235 discloses a method for stabilizing DNA as a complex with chitosan. Japanese Patent Application Laid-Open No. 2001-199903 describes a complex of a nucleic acid and chitosan which is considered suitable for the treatment in the gene field. Japanese Patent Application Laid-Open No. 2001-500109 discloses a composition comprising a granular complex of chitosan and nucleic acid as a composition suitable for gene delivery to epithelial cells.
JP 2001-327591 A JP-A-10-77235 JP 2001-199903 A JP 2001-500109 A

DNAをキトサン複合体とすることにより、DNAの機能を損なうことなく安定性良く目的とする用途に利用可能となるという利点が得られる。更に、DNAもキトサンも生物由来の素材であることから、DNA/キトサン複合体はDNA/合成脂質複合体より安全性・代謝面でのリスクが小さいと考えられ、またキトサンが合成脂質より大量且つ安価に調達できることから商業的にも有利と見なされる。しかしながら、DNA/合成脂質複合体と異なり、DNA/キトサン複合体は有機溶媒に不溶であることから、成型加工が極めて困難であるという欠点を有していた。   By using DNA as a chitosan complex, there is an advantage that it can be used for the intended purpose with good stability without impairing the function of the DNA. Furthermore, since both DNA and chitosan are biological materials, DNA / chitosan complexes are considered to have less safety and metabolic risks than DNA / synthetic lipid complexes, and chitosan is more abundant than synthetic lipids. Since it can be procured at a low cost, it is considered commercially advantageous. However, unlike the DNA / synthetic lipid complex, the DNA / chitosan complex is insoluble in an organic solvent and thus has a drawback that it is extremely difficult to mold.

本発明の目的は、DNAの二重らせん構造が維持されてその特性を安定して得ることのできるDNA/キトサン複合体を、医療用あるいは歯科用材料などの所望とする目的に適した形状に容易に成形可能とする成形方法を提供することにある。   An object of the present invention is to form a DNA / chitosan complex that maintains the double helix structure of DNA and can stably obtain its properties into a shape suitable for a desired purpose such as a medical or dental material. An object of the present invention is to provide a molding method that enables easy molding.

本発明者らは、DNA/キトサン複合体の製造方法及びその特性について種々の検討を行った結果、DNAとキトサンを脱イオン水で反応させて得られる沈殿物を緩衝液で洗浄してから凍結乾燥することで、医療用あるいは歯科用材料として適用可能なDNA/キトサン複合体が得られ、更に、DNAとキトサンの配合比、洗浄用緩衝液の種類や濃度などの製造条件を適宜変更することで、DNA/キトサン複合体におけるDNAの含有割合、性状、気孔率などを調整可能であるとの知見を得た。更に、このDNA/キトサン複合体を緩衝液と接触させた状態とすることで成形可能な状態が得られるとの新規な知見を得た。本発明は、かかる本発明者らの新規な知見に基づいてなされたものである。   As a result of various studies on the production method and characteristics of the DNA / chitosan complex, the present inventors have found that the precipitate obtained by reacting DNA and chitosan with deionized water is washed with a buffer and then frozen. By drying, a DNA / chitosan complex applicable as a medical or dental material can be obtained, and furthermore, the production conditions such as the mixing ratio of DNA and chitosan, the type and concentration of the washing buffer solution can be appropriately changed. Thus, it was found that the DNA content, properties, porosity, etc. in the DNA / chitosan complex can be adjusted. Furthermore, a novel finding was obtained that a moldable state was obtained by bringing the DNA / chitosan complex into contact with a buffer solution. The present invention has been made based on the novel findings of the present inventors.

本発明のDNA/キトサン複合体の成形方法の第一の態様は、
DNA/キトサン複合体を成型用の型内に充填する工程と、
前記型内に充填されたDNA/キトサン複合体に緩衝液を供給する工程と、
前記型内の前記緩衝液を含むDNA/キトサン複合体を該型内に充填した状態で凍結乾燥し、該型の形状に成型されたDNA/キトサン複合体成型物を得る工程と
を有することを特徴とするDNA/キトサン複合体の成形方法である。
The first aspect of the method for molding a DNA / chitosan complex of the present invention is:
Filling the DNA / chitosan complex into a mold for molding;
Supplying a buffer to the DNA / chitosan complex filled in the mold;
And lyophilizing the DNA / chitosan complex containing the buffer solution in the mold in a state of filling the mold to obtain a DNA / chitosan complex molded product molded into the shape of the mold. This is a method for forming a DNA / chitosan complex.

本発明のDNA/キトサン複合体の成形方法の第二の態様は、
DNA/キトサン複合体を緩衝液中に投与し、該DNA/キトサン複合体の塊を得る工程と、
前記該DNA/キトサン複合体の塊を成型用の型内に充填する工程と、
前記型内のDNA/キトサン複合体を該型内に充填した状態で凍結乾燥し、該型の形状に成型されたDNA/キトサン複合体成型物を得る工程と
を有することを特徴とするDNA/キトサン複合体の成形方法である。
The second embodiment of the method for forming a DNA / chitosan complex of the present invention comprises:
Administering the DNA / chitosan complex in a buffer to obtain a mass of the DNA / chitosan complex;
Filling the DNA / chitosan complex mass into a mold for molding;
And a step of freeze-drying the DNA / chitosan complex in the mold in a state filled in the mold to obtain a DNA / chitosan complex molded product molded into the shape of the mold. This is a method for forming a chitosan composite.

本発明のDNA/キトサン複合体の成形方法の第三の態様は、
DNA/キトサン複合体の成形方法において、
DNA/キトサン複合体の水性スラリーを緩衝液中に投与し、投入状態に応じた形状の固まりを得る工程と、
前記該DNA/キトサン複合体の塊を凍結乾燥し、前記投入状態に応じた形状のDNA/キトサン複合体成形物を得る工程と
を有することを特徴とするDNA/キトサン複合体の成形方法である。
The third aspect of the method for molding the DNA / chitosan complex of the present invention is:
In a method for forming a DNA / chitosan complex,
Administering an aqueous slurry of DNA / chitosan complex into a buffer solution to obtain a mass of a shape according to the charged state;
And a step of freeze-drying the mass of the DNA / chitosan complex to obtain a DNA / chitosan complex molded product having a shape corresponding to the charged state. .

本発明によれば、DNAの特性を安定して得ることが可能であり、各種用途に有用であるDNA/キトサン複合体を所望の目的に応じた形状に容易に成形可能な方法を提供することができる。   According to the present invention, there is provided a method capable of stably obtaining DNA characteristics and easily forming a DNA / chitosan complex useful for various applications into a shape according to a desired purpose. Can do.

本発明のDNA/キトサン複合体の成形方法は、DNA/キトサン複合体に成形用緩衝液を作用させることで成形性を持たせる点に特徴を有する。以下、本発明の各態様について説明する。   The method for molding a DNA / chitosan complex of the present invention is characterized in that moldability is imparted by allowing a molding buffer to act on the DNA / chitosan complex. Hereinafter, each aspect of the present invention will be described.

本発明のDNA/キトサン複合体の成形方法の第一の態様は、
DNA/キトサン複合体を成型用の型内に充填する工程と、
前記型内に充填されたDNA/キトサン複合体に緩衝液を供給する工程と、
前記型内の前記緩衝液を含むDNA/キトサン複合体を該型内に充填した状態で凍結乾燥し、該型の形状に成型されたDNA/キトサン複合体成型物を得る工程と
を有する。
The first aspect of the method for molding a DNA / chitosan complex of the present invention is:
Filling the DNA / chitosan complex into a mold for molding;
Supplying a buffer to the DNA / chitosan complex filled in the mold;
And a step of freeze-drying the DNA / chitosan complex containing the buffer solution in the mold while filling the mold to obtain a molded DNA / chitosan complex molded into the shape of the mold.

この方法では、まず、DNA/キトサン複合体を適当な大きさの塊とし、必要に応じて緩衝液で洗浄し、型内に充填する。ここで用いる型は、所望の形状へのDNA/キトサン複合体の成形を可能する構造を有する。更に、この型は、後述する凍結乾燥が可能となるように開閉可能な部分を有することが好ましい。型内に充填するDNA/キトサン複合体の塊のサイズや量は、成形後に得られる成形物において所望とする密度や空孔率などに応じて適宜選択することができる。大きな塊のDNA/キトサン複合体を用いる場合はこれを粉砕して粉体状とし、これを型内に充填するとよい。型に充填するまえにDNA/キトサン複合体を緩衝液で洗浄してもよく、この場合に用いる洗浄用緩衝液は、成形用の緩衝液と同じものが好適に利用できる。DNA/キトサン複合体を型に充填したところで、これに成形用の緩衝液を供給する。供給方法としては、型の一部を開放状態として、型内のDNA/キトサン複合体の充填状態を維持しつつ、成形用の緩衝液に浸漬する方法が好適である。また、型内に成形用緩衝液を注入する方法を用いることもできる。   In this method, first, the DNA / chitosan complex is formed into a lump of an appropriate size, washed with a buffer as necessary, and filled into a mold. The mold used here has a structure that enables the DNA / chitosan complex to be formed into a desired shape. Furthermore, this mold preferably has a portion that can be opened and closed so as to enable freeze-drying described later. The size and amount of the DNA / chitosan complex mass to be filled in the mold can be appropriately selected according to the density and porosity desired in the molded product obtained after molding. When a large lump of DNA / chitosan complex is used, it may be pulverized into powder and filled in a mold. Before filling the mold, the DNA / chitosan complex may be washed with a buffer. In this case, the same washing buffer as that for molding can be preferably used. When the DNA / chitosan complex is filled in the mold, a molding buffer is supplied thereto. As a supply method, a method in which a part of the mold is opened and immersed in a buffer solution for molding while maintaining the filled state of the DNA / chitosan complex in the mold is preferable. A method of injecting a molding buffer into the mold can also be used.

型内のDNA/キトサン複合体に成形用緩衝液を供給した後、必要に応じて型内のDNA/キトサン複合体を加圧して成形性を高めてもよい。また、必要に応じて型内の余分な液体を除去してもよい。このようにして、成型用緩衝液を供給した型内のDNA/キトサン複合体を、型内での充填状態を維持したまま凍結乾燥にかける。所定の乾燥状態が得られた段階で、型から成形物を取り出す。こうして得た成形物は、型の構造に応じて付与された形状を有する。   After the molding buffer is supplied to the DNA / chitosan complex in the mold, the moldability may be improved by pressing the DNA / chitosan complex in the mold as necessary. Moreover, you may remove the excess liquid in a type | mold as needed. In this manner, the DNA / chitosan complex in the mold supplied with the molding buffer is subjected to lyophilization while maintaining the filling state in the mold. When the predetermined dry state is obtained, the molded product is taken out from the mold. The molded product thus obtained has a shape given according to the structure of the mold.

本発明のDNA/キトサン複合体の成形方法の第二の態様は、
DNA/キトサン複合体を緩衝液中に投与し、該DNA/キトサン複合体の塊を得る工程と、
前記該DNA/キトサン複合体の塊を成型用の型内に充填する工程と、
前記型内のDNA/キトサン複合体を該型内に充填した状態で凍結乾燥し、該型の形状に成型されたDNA/キトサン複合体成型物を得る工程と
を有する。
The second embodiment of the method for forming a DNA / chitosan complex of the present invention comprises:
Administering the DNA / chitosan complex in a buffer to obtain a mass of the DNA / chitosan complex;
Filling the DNA / chitosan complex mass into a mold for molding;
A step of freeze-drying the DNA / chitosan complex in the mold filled in the mold to obtain a molded DNA / chitosan complex molded into the shape of the mold.

この方法では、まず、DNA/キトサン複合体を成形用緩衝液に投入して、緩衝液中で成形可能な塊とする。成形用緩衝液へのDNA/キトサン複合体の投入には、DNA/キトサン複合体の水性スラリーを調製して、これを成形用緩衝液に投入する方法が好適である。例えば、DNA/キトサン複合体の水性スラリーをシリンジなどの適当な供給手段を用いて成形用緩衝液中に押し出して適当な大きさ及び形状の塊とする。水性スラリーの調製は、DNA/キトサン複合体を適当な粒径の粉体として、これを水と混合することにより得ることができる。DNA/キトサン複合体の水性スラリーを成形用緩衝液中に投与すると、スラリー状から成形可能な塊が形成される。次に、この塊を、成形用の型内に充填する。この状態で、必要に応じて型内のDNA/キトサン複合体を加圧して成形性を高めてもよく、また、必要に応じて型内の余分な液体を除去してもよい。   In this method, first, the DNA / chitosan complex is put into a molding buffer solution to form a mass that can be molded in the buffer solution. For the introduction of the DNA / chitosan complex into the molding buffer, a method of preparing an aqueous slurry of the DNA / chitosan complex and introducing it into the molding buffer is suitable. For example, an aqueous slurry of DNA / chitosan complex is extruded into a molding buffer solution using an appropriate supply means such as a syringe to obtain a lump of an appropriate size and shape. The aqueous slurry can be prepared by preparing the DNA / chitosan complex as a powder having an appropriate particle size and mixing it with water. When an aqueous slurry of DNA / chitosan complex is administered into a molding buffer, a moldable mass is formed from the slurry. Next, this lump is filled into a mold for molding. In this state, if necessary, the DNA / chitosan complex in the mold may be pressurized to improve moldability, and if necessary, excess liquid in the mold may be removed.

こうして型内に充填されたDNA/キトサン複合体を、型内での充填状態を維持したまま凍結乾燥にかける。所定の乾燥状態が得られた段階で、型から成形物を取り出す。こうして得た成形物は、型の構造に応じて付与された形状を有する。なお、型内に充填する塊は、1つでもよいし、2以上のでもよい。   The DNA / chitosan complex thus filled in the mold is freeze-dried while maintaining the filled state in the mold. When the predetermined dry state is obtained, the molded product is taken out from the mold. The molded product thus obtained has a shape given according to the structure of the mold. Note that the number of lumps filled in the mold may be one, or two or more.

本発明のDNA/キトサン複合体の成形方法の第三の態様は、
DNA/キトサン複合体の成形方法において、
DNA/キトサン複合体の水性スラリーを緩衝液中に投与し、投入状態に応じた形状の固まりを得る工程と、
前記該DNA/キトサン複合体の塊を凍結乾燥し、前記投入状態に応じた形状のDNA/キトサン複合体成形物を得る工程と
を有する。
The third aspect of the method for molding the DNA / chitosan complex of the present invention is:
In a method for forming a DNA / chitosan complex,
Administering an aqueous slurry of DNA / chitosan complex into a buffer solution to obtain a mass of a shape according to the charged state;
A step of freeze-drying the DNA / chitosan complex mass to obtain a DNA / chitosan complex molded product having a shape corresponding to the charged state.

この方法では、DNA/キトサン複合体の水性スラリーを所望の形状で成形用緩衝液中に投与し、その形状を有する塊を得る。この塊をその形状を維持しつつ凍結乾燥することで、所望の形状を有する成形物を得ることができる。例えば、シリンジにDNA/キトサン複合体の水性スラリーを充填し、液滴状として成形用緩衝液中に投与することで、液滴状の塊を得ることができる。あるいは、シリンジの押し出し口の形状を適宜選択して水性スラリーを押し出すことで、糸状や帯状の塊を成形用緩衝液中に得ることができる。また、成形用の緩衝液中に得た液滴状の塊の頭部をへらなどを用いて平らにして、ディスク状とすることも可能である。更に、成形用緩衝液中に型を用意しておくことで、型の形状に応じた塊を得ることもできる。   In this method, an aqueous slurry of DNA / chitosan complex is administered into a molding buffer in a desired shape to obtain a mass having that shape. A molded product having a desired shape can be obtained by freeze-drying the mass while maintaining its shape. For example, a droplet-like lump can be obtained by filling a syringe with an aqueous slurry of DNA / chitosan complex and administering it as a droplet into a molding buffer. Alternatively, a thread-like or belt-like lump can be obtained in the molding buffer by appropriately selecting the shape of the syringe outlet and extruding the aqueous slurry. It is also possible to flatten the head of the droplet-shaped mass obtained in the buffer solution for molding using a spatula or the like to form a disk shape. Furthermore, a lump corresponding to the shape of the mold can be obtained by preparing the mold in the molding buffer.

本発明の成形方法に用いるDNA/キトサン複合体は、成形用緩衝液によって成形性が付与できるものであればよい。なかでも、複合体製造用の水性媒体中でDNAとキトサンを反応させて得られる沈殿物を緩衝液で洗浄して得られたものが好ましい。このDNA/キトサン複合体では、DNAとキトサンの配合比、洗浄用緩衝液の種類や濃度などの製造条件を適宜変更することで、DNA/キトサン複合体におけるDNAの含有割合、性状、気孔率などを調整可能である。   The DNA / chitosan complex used in the molding method of the present invention may be any as long as moldability can be imparted by the molding buffer. Among these, those obtained by washing a precipitate obtained by reacting DNA and chitosan in an aqueous medium for producing a complex with a buffer solution are preferable. In this DNA / chitosan complex, the content ratio, properties, porosity, etc. of DNA in the DNA / chitosan complex can be changed by appropriately changing the production conditions such as the mixing ratio of DNA and chitosan and the type and concentration of the washing buffer. Can be adjusted.

前記DNA/キトサン複合体を形成するDNAとしては、天然DNAおよび合成DNAを利用することができ、医療用または歯科用など成形物の目的用途に応じて選択することができる。天然DNAとしては、細菌ウイルスのλファージDNA、大腸菌染色体DNA、仔牛胸腺DNA、サケ精子DNAを挙げることができる。また、合成DNAは、ポリ(dA)、ポリ(dT)、ポリ(dG)、ポリ(dC)、ポリ(dA−dT)、ポリ(dG−dC)などを用いて合成装置によって合成可能な、塩基配列の異なる種々の合成DNA;ポリ(A)、ポリ(T)、ポリ(G)、ポリ(U)、ポリ(A−T)、ポリ(G−U)などを用いて合成装置により合成可能な、塩基配列の異なる種々の合成RNA;ポリ(dG)、ポリ(U)、ポリ(G)、ポリ(dC)ポリ(dA−dT)、ポリ(A−T)などのDNA/RNAハイブリッドを用いて合成装置によって合成可能な、相補的塩基対を有するDNA/RNAハイブリッドを挙げることができる。これらは必要に応じて単独であるいは組み合わせて使用することができる。   As the DNA forming the DNA / chitosan complex, natural DNA and synthetic DNA can be used, and can be selected according to the intended use of the molded product such as medical use or dental use. Examples of natural DNA include bacterial virus λ phage DNA, Escherichia coli chromosomal DNA, calf thymus DNA, and salmon sperm DNA. Synthetic DNA can be synthesized by a synthesizer using poly (dA), poly (dT), poly (dG), poly (dC), poly (dA-dT), poly (dG-dC), etc. Synthesizing using various synthetic DNAs with different base sequences: poly (A), poly (T), poly (G), poly (U), poly (A-T), poly (G-U), etc. Possible various synthetic RNAs with different base sequences: DNA / RNA hybrids such as poly (dG), poly (U), poly (G), poly (dC) poly (dA-dT), poly (A-T), etc. And a DNA / RNA hybrid having a complementary base pair that can be synthesized by a synthesizer. These can be used alone or in combination as required.

このようなDNAは、二重らせんを形成している四種類の塩基[シトシン(C)、グアニン(G)、アデニン(A)、チミン(T)]に種々の基(例えばリン酸含有基を末端に有する基)などが結合した構造を有しており、このDNA全体としては、例えば上記の末端に結合したリン酸基などに起因してアニオン性を示す。   Such DNA has various groups (for example, phosphate-containing groups) on four types of bases [cytosine (C), guanine (G), adenine (A), thymine (T)] forming a double helix. The entire DNA has an anionic property due to, for example, the phosphate group bonded to the terminal.

このようなDNA自体は、二重らせん構造を有する紐状物であり、また、このDNAは水に溶解することから、このDNA自体に成形性はない。DNAがアニオン性を有していることを利用して、アニオン性のDNAと、カチオン性のキトサンとを静電的に反応させることでDNA/キトサン複合体を得ることができる。このようにして複合体となることで、DNAは実質的に水に溶解しなくなる。また、有機溶剤に対する溶解性も低くなる。   Such DNA itself is a string having a double helix structure, and since this DNA dissolves in water, this DNA itself has no moldability. A DNA / chitosan complex can be obtained by electrostatically reacting anionic DNA with cationic chitosan by utilizing the fact that DNA has anionic property. By forming a complex in this manner, DNA is substantially not dissolved in water. Moreover, the solubility with respect to an organic solvent also becomes low.

DNAに複合化させるキトサンとしては、本発明の方法に従って成形可能な複合体を形成できるものであればよい。中でも、医療用材料および歯科用材料等とする場合には、分子量320(グルコサミン残基数2)以上であるキトサンが好ましい。   Any chitosan complexed with DNA may be used as long as it can form a complex that can be molded according to the method of the present invention. Of these, chitosan having a molecular weight of 320 (number of glucosamine residues 2) or more is preferable when it is used as a medical material or a dental material.

キトサンは、カニやエビの殻、昆虫類、植物、微生物などを原料として調製することができる。分子量320(グルコサミン残基数2)以上のもの、好ましくは分子量1600(グルコサミン残基数10)以上のキトサンを使用することができる。このことは、DNAの水に対する不溶性を発現させるために、分子量1万以上のキトサンであることが望ましい。さらに分子量が小さく塩酸等と塩を形成しているキトサンを使用した場合には、DNAとの反応物が水溶性であり、この反応物をDNAの溶媒である水性媒体から分離することが困難なために複合体を形成する目的の場合には適しないからである。   Chitosan can be prepared using crab and shrimp shells, insects, plants, microorganisms and the like as raw materials. Chitosan having a molecular weight of 320 (glucosamine residue number 2) or more, preferably a molecular weight of 1600 (glucosamine residue number 10) or more can be used. This is preferably chitosan having a molecular weight of 10,000 or more in order to express insolubility of DNA in water. In addition, when chitosan having a small molecular weight and forming a salt with hydrochloric acid or the like is used, the reaction product with DNA is water-soluble, and it is difficult to separate this reaction product from the aqueous medium that is the solvent for DNA. Therefore, it is not suitable for the purpose of forming a complex.

DNAとキトサンの反応は、水性媒体中で行うことができる。例えば、DNAの水溶液を攪拌しているキトサン水溶液に添加して混合することによりこれらを反応させることができる。なお、キトサンの水溶液はその溶解状態を確保するために酸やアルカリを用いてpHを調整したものでもよい。例えば、pH5などの酸性条件の水溶液が好適に利用できる。   The reaction between DNA and chitosan can be carried out in an aqueous medium. For example, these can be reacted by adding and mixing an aqueous solution of DNA to a stirring chitosan aqueous solution. The aqueous solution of chitosan may be adjusted in pH using acid or alkali in order to ensure its dissolved state. For example, an aqueous solution under acidic conditions such as pH 5 can be suitably used.

DNAとキトサンの配合比は、DNA/キトサン複合体成形物の用途に応じて選択することができる。例えば、1/9〜9/1、好ましくは1/1〜1/1.5(モル比)の範囲から選択することができる。   The compounding ratio of DNA and chitosan can be selected according to the use of the DNA / chitosan composite molded product. For example, it can be selected from the range of 1/9 to 9/1, preferably 1/1 to 1 / 1.5 (molar ratio).

DNAをキトサンを水性媒体中で反応させることによりDNA/キトサン複合体の沈殿を生じる。この沈殿を水あるいは各種の緩衝液で洗浄し、必要に応じて、更に水洗し、余分な水分を遠心分離などで除去してから、乾燥することでDNA/キトサン複合体の乾燥物を得ることができる。   Reaction of DNA with chitosan in an aqueous medium results in precipitation of the DNA / chitosan complex. This precipitate is washed with water or various buffers, and if necessary, further washed with water, excess water is removed by centrifugation, etc., and dried to obtain a dried DNA / chitosan complex. Can do.

沈殿の洗浄用の緩衝液としては、トリス緩衝液、ホウ酸緩衝液、HEPES緩衝液、酢酸緩衝液、クエン酸緩衝液、グリシン緩衝液、バルビツール酸緩衝液、フタル酸緩衝液、カコジル酸緩衝液、炭酸緩衝液、Bis−トリス緩衝液、Bis−トリスープロパン緩衝液、MES緩衝液、ADA緩衝液、PIPES緩衝液、ACES緩衝液、コラミンクロリド緩衝液、BES緩衝液、MOPS緩衝液、TES緩衝液、HEPPS緩衝液、Tricine緩衝液、グリシンアミド緩衝液、Bicine緩衝液、TAPS緩衝液、CHES緩衝液、CAPS緩衝液、リン酸緩衝液などの中から選択することができる。緩衝液の濃度やpHも目的とするDNA/キトサン複合体の性状や物性が得られるように自由に選択することができる。   Buffers for washing precipitates include Tris buffer, borate buffer, HEPES buffer, acetate buffer, citrate buffer, glycine buffer, barbiturate buffer, phthalate buffer, cacodylate buffer Solution, carbonate buffer solution, Bis-Tris buffer solution, Bis-Tris-propane buffer solution, MES buffer solution, ADA buffer solution, PIPES buffer solution, ACES buffer solution, collamine chloride buffer solution, BES buffer solution, MOPS buffer solution, It can be selected from TES buffer, HEPPS buffer, Tricine buffer, glycinamide buffer, Bicine buffer, TAPS buffer, CHES buffer, CAPS buffer, phosphate buffer and the like. The concentration and pH of the buffer solution can be freely selected so that the desired properties and physical properties of the DNA / chitosan complex can be obtained.

このようにして得られたDNA/キトサン複合体乾燥物を必要に応じて粉砕して本発明にかかる成形方法に用いることができる。このDNA/キトサン複合体では、DNAの二重らせん構造が破壊されずにほぼ完全に残されているので、このDNA/キトサン複合体を用いることでDNAの機能を安定して効率良く利用することが可能となる。   The DNA / chitosan complex dried product thus obtained can be pulverized if necessary and used in the molding method according to the present invention. In this DNA / chitosan complex, the double helix structure of DNA is almost completely left without being destroyed. Therefore, by using this DNA / chitosan complex, the function of DNA can be used stably and efficiently. Is possible.

一方、本発明の成形方法で用いる成形用緩衝液としては、リン酸緩衝液、HEPES緩衝液などを用いることができる。緩衝液の濃度は、DNAの機能が損なわれない濃度を用いればよく、pHは、好ましくはpH7から8の範囲から選択することができる。   On the other hand, as a molding buffer used in the molding method of the present invention, a phosphate buffer, a HEPES buffer, or the like can be used. The concentration of the buffer may be a concentration that does not impair the function of the DNA, and the pH can be preferably selected from the range of pH 7 to 8.

以上説明した本発明の成形方法により成形したDNA/キトサン複合体成形物に、その用途に応じて、医科用あるいは歯科用の薬理活性成分などを付着させて利用することもできる。   The DNA / chitosan composite molded product molded by the molding method of the present invention described above can be used by adhering a medical or dental pharmacologically active component or the like depending on its use.

以下、実施例により本発明を更に詳細に説明する。   Hereinafter, the present invention will be described in more detail with reference to examples.

実施例1(DNA/キトサン複合体の製造;その1)
(a)用いた溶液
・DNA溶液;サケ精子由来DNA(300塩基対、ニチロ社製)を蒸留水に溶解する。(5mg/1ml)
・キトサン溶液;キトサン(分子量13万、ニチロ社製)を0.2N HCl 50mlに溶解した。この溶液に0.2N NaOHと蒸留水を徐々に加え、pH5の溶液100mlとした。(5mg/1ml)
(b)キトサン水溶液とDNA水溶液からの合成
撹拌しているキトサン水溶液100mlにDNA水溶液を加え、1時間反応させた。反応後生じた沈殿物を遠心分離した。得られた沈殿物をトリス塩酸緩衝液(10mM、pH7.2)(以下Tris−HCl緩衝液という)60mlで洗浄し、再度遠心分離した。Tris−HCl緩衝液洗浄は2回行った。次に、蒸留水60mlで洗浄した後、遠心分離を行った。蒸留水洗浄は3回行った。得られた白色沈殿物を凍結乾燥した。収量は600mgで、リンの定量よりDNA/キトサン複合体(サンプルA)の分子量比率(モル比)は0.95/1であった。
Example 1 (Production of DNA / chitosan complex; Part 1)
(A) Solution / DNA solution used: Salmon sperm-derived DNA (300 base pairs, manufactured by Nichiro) is dissolved in distilled water. (5mg / 1ml)
Chitosan solution: Chitosan (molecular weight 130,000, manufactured by Nichiro) was dissolved in 50 ml of 0.2N HCl. To this solution, 0.2N NaOH and distilled water were gradually added to make 100 ml of pH 5 solution. (5mg / 1ml)
(B) Synthesis from chitosan aqueous solution and DNA aqueous solution The DNA aqueous solution was added to 100 ml of the stirring chitosan aqueous solution and allowed to react for 1 hour. The precipitate formed after the reaction was centrifuged. The resulting precipitate was washed with 60 ml of Tris-HCl buffer (10 mM, pH 7.2) (hereinafter referred to as Tris-HCl buffer) and centrifuged again. Washing with Tris-HCl buffer was performed twice. Next, after washing with 60 ml of distilled water, centrifugation was performed. Washing with distilled water was performed 3 times. The resulting white precipitate was lyophilized. The yield was 600 mg, and the molecular weight ratio (molar ratio) of the DNA / chitosan complex (sample A) was 0.95 / 1 from the quantification of phosphorus.

上記の製造方法の中で反応物の濃度を変えた場合、すなわちDNA水溶液(7.5mg/1ml)とキトサン水溶液(2.5mg/1ml)あるいはDNA水溶液(2.5mg/1ml)とキトサン水溶液(7.5mg/1ml)を用いるとDNA/キトサン複合体の分子量比率(モル比)は1.28/1と0.88/1で、収量は700mgと300mgであつた。   When the concentration of the reaction product is changed in the above production method, that is, an aqueous DNA solution (7.5 mg / 1 ml) and an aqueous chitosan solution (2.5 mg / 1 ml) or an aqueous DNA solution (2.5 mg / 1 ml) and an aqueous chitosan solution ( 7.5 mg / 1 ml), the molecular weight ratio (molar ratio) of the DNA / chitosan complex was 1.28 / 1 and 0.88 / 1, and the yield was 700 mg and 300 mg.

上記の製造方法の中で緩衝液の種類を変えた場合はDNA/キトサン複合体中の気孔率と気孔径が異なる。   When the kind of the buffer is changed in the above production method, the porosity and the pore diameter in the DNA / chitosan complex are different.

例えば、リン酸緩衝液(10 mM、pH7.2、0.9%NaCl)(以下PBS緩衝液という)、HEPES緩衝液(10mM、pH7.2)よりTris−HCl緩衝液やホウ酸緩衝液(10mM,pH7.2)で洗浄したDNA/キトサン複合体中の気孔の数は多く、形態も大きい。   For example, phosphate buffer (10 mM, pH 7.2, 0.9% NaCl) (hereinafter referred to as PBS buffer), HEPES buffer (10 mM, pH 7.2), Tris-HCl buffer or borate buffer ( The DNA / chitosan complex washed with 10 mM, pH 7.2) has a large number of pores and a large morphology.

上記の製造方法の中でDNA/キトサンの分子量比率(モル比)が異なれば、同じ緩衝液で処理してもDNA/キトサン反応物中の気孔率と気孔径が異なる。例えば、Tris−HCl緩衝液で洗浄したDNA/キトサン複合体中のDNA含有量の少ない物の方が気孔率は大きい。   If the molecular weight ratio (molar ratio) of DNA / chitosan is different in the above production method, the porosity and the pore diameter in the DNA / chitosan reaction product will be different even when treated with the same buffer. For example, the porosity of a DNA / chitosan complex washed with a Tris-HCl buffer is lower when the DNA content is lower.

実施例2(DNA/キトサン複合体のディスクの作製)
実施例1で得たDNA/キトサン複合体(サンプルA)を粉砕機等で粉砕し、実施例1で用いたのと同様のリン酸緩衝液で洗浄後、図1で示すように中心部が円形にくり貫かれた孔になっているシリコーンパッキンからなる型(外径20、内径8、厚さ2mm)の孔に入れた。なお、型の底部は、ステンレス板(20×20×1mm)に接着剤で固定されている。ろ紙などでDNA/キトサン複合体の水分を吸い取りながら平らにした後、ナイロンメッシュ(PE24、526μm)で数回押し付けて更に平らにし、同じメッシュで蓋をした。これを同様のリン酸緩衝液に10分間浸した後、メッシュを取り除き、DNA/キトサン複合体複合体の水分をろ紙などで除いた。そしてポリエチレンフィルムとステンレス板で蓋をし、液体窒素に漬けた。引上げてポリエチレンフィルムとステンレス板を除いた後、前述のナイロンメッシュで蓋をして再度液体窒素に漬けた。引上げてナイロンメッシュを除いて得られたディスク状型内のDNA/キトサン複合体を凍結乾燥して、図2の写真に示す歯科医療用などに好適な性状を有するディスク状のDNA/キトサン複合体を得た。
Example 2 (Preparation of DNA / chitosan complex disk)
The DNA / chitosan complex (sample A) obtained in Example 1 was pulverized with a pulverizer or the like, washed with a phosphate buffer similar to that used in Example 1, and then the central part as shown in FIG. It was put in a hole of a mold (outer diameter 20, inner diameter 8, thickness 2 mm) made of silicone packing which was a hole cut into a circle. Note that the bottom of the mold is fixed to a stainless steel plate (20 × 20 × 1 mm) with an adhesive. The DNA / chitosan complex was flattened while sucking moisture of the DNA / chitosan complex with a filter paper or the like, then pressed several times with a nylon mesh (PE24, 526 μm), and then covered with the same mesh. This was immersed in the same phosphate buffer for 10 minutes, then the mesh was removed, and the water of the DNA / chitosan complex was removed with filter paper or the like. Then, it was covered with a polyethylene film and a stainless steel plate and immersed in liquid nitrogen. After pulling up and removing the polyethylene film and the stainless steel plate, it was covered with the aforementioned nylon mesh and immersed in liquid nitrogen again. The DNA / chitosan complex in the disk-shaped mold obtained by pulling up and removing the nylon mesh is freeze-dried, and the disk-shaped DNA / chitosan complex having properties suitable for dentistry and the like shown in the photograph of FIG. Got.

実施例3(糸状、ボール状、あるいは自由に成型加工されたDNA/キトサン複合体の作製方法)
実施例1で得たDNA/キトサン複合体(サンプルA)に水を加えてクリーム状のスラリーとし、シリンジに入れた。実施例2で用いたのと同様のリン酸緩衝液にこのシリンジ先端の針からスラリーを注入すると、即座に注入された形状で形態が維持されたDNA/キトサン複合体が得られた。この場合、ニードルの先端から連続してリン酸緩衝液に注入すると糸状に、また涙滴状にしてリン酸バッファー中に落とし込むとボール状までの形態にすることができた。さらに上記の糸状複合体を数個を積層する要領でモールドに入れ、余剰の水分をろ紙等で吸い取って凍結乾燥すると、モールドに応じた形態に自由に成型することができた。
Example 3 (Method for producing DNA / chitosan complex formed into a string, ball, or freely molded)
Water was added to the DNA / chitosan complex (sample A) obtained in Example 1 to form a creamy slurry, which was placed in a syringe. When the slurry was injected from the needle at the tip of the syringe into the same phosphate buffer as used in Example 2, a DNA / chitosan complex whose shape was maintained immediately after injection was obtained. In this case, when the needle was continuously injected into the phosphate buffer from the tip of the needle, it could be formed into a thread shape, and when it was dropped into the phosphate buffer as a tear drop, it could be in the form of a ball. Furthermore, when the above-mentioned thread-like composite was put into a mold in a manner of laminating several pieces, and excess water was absorbed with a filter paper and freeze-dried, it could be freely formed into a form corresponding to the mold.

実施例4(DNA/キトサン複合体の製造;その2)
メインのピークを300bp付近に持つ低分子二本鎖DNA(LdsDNA)1gを脱イオン水で溶解後、最終的に200ml(5mg/ml)となるようにした。一方、モル比でデオキシヌクレオチド(dNMP)に対して1.5倍量となるようにキトサン(分子量13万、ニチロ社製)を測り取り、0.2NHClを用いて溶解後、0.2NNaOHを用いて最終的にpH5.0、5mg/ml溶液となるようにした。その後、LdsDNA溶液とキトサン溶液を混合し、1時間室温で撹拌した後、遠心分離(10000rpm、5分)により沈殿物を回収した。この沈殿物に脱イオン水100mlを添加し、遠心分離(8000rpm、5分)した。この洗浄工程を2回行った。得られた沈殿物を凍結乾燥し、DNA/キトサン複合体として回収した。
Example 4 (Production of DNA / chitosan complex; Part 2)
After dissolving 1 g of low molecular weight double-stranded DNA (LdsDNA) having a main peak at around 300 bp with deionized water, the final volume was 200 ml (5 mg / ml). On the other hand, chitosan (molecular weight 130,000, manufactured by Nichiro) was measured so that the molar ratio was 1.5 times that of deoxynucleotide (dNMP), dissolved in 0.2N HCl, and then 0.2 NNaOH was used. Finally, the solution was adjusted to pH 5.0 and 5 mg / ml. Thereafter, the LdsDNA solution and the chitosan solution were mixed and stirred for 1 hour at room temperature, and then the precipitate was collected by centrifugation (10000 rpm, 5 minutes). 100 ml of deionized water was added to the precipitate and centrifuged (8000 rpm, 5 minutes). This washing step was performed twice. The resulting precipitate was lyophilized and recovered as a DNA / chitosan complex.

実施例5(DNA/キトサン複合体ペレット成型法)
実施例4の方法にて回収したDNA/キトサン複合体200mgに脱イオン水1mlを加え均一化させるために乳鉢ですり潰してクリーム状のスラリーを得た。このスラリーを、10mMリン酸緩衝液(10mM Na2HPO4・12H2O、10mM KH2PO4;pH7.4、100mM NaCl及び3mM KClを含む)50ml中に添加し、10分間静置し、緩衝液中に塊を得た。得られた塊を、底面を有する円形の枠内に充填し、余分な水分をキムワイプで除去しながら成型化し、枠内に充填した状態で凍結乾燥してペレットを得た。
Example 5 (DNA / chitosan complex pellet molding method)
To 200 mg of the DNA / chitosan complex recovered by the method of Example 4, 1 ml of deionized water was added and ground with a mortar to obtain a creamy slurry. This slurry is added to 50 ml of 10 mM phosphate buffer (10 mM Na 2 HPO 4 · 12H 2 O, 10 mM KH 2 PO 4 ; pH 7.4, containing 100 mM NaCl and 3 mM KCl) and left to stand for 10 minutes. Lumps were obtained in the buffer. The obtained lump was filled in a circular frame having a bottom surface, molded while removing excess moisture with Kimwipe, and freeze-dried in a state filled in the frame to obtain pellets.

更に、リン酸緩衝液の濃度を10mMから100mMに上げたところ、ペレット強度が構向上した。   Furthermore, when the concentration of the phosphate buffer was increased from 10 mM to 100 mM, the pellet strength improved.

実施例6
実施例5で得たスラリーをシリンジに充填し、実施例5で用いたもとと同様のリン酸バッファー中に糸状に押し出した。得られた糸状の塊をその形状を維持して凍結乾燥することで、糸状の成形物を得た。
Example 6
The slurry obtained in Example 5 was filled in a syringe and extruded into a similar phosphate buffer as used in Example 5 in a thread form. The obtained thread-like lump was freeze-dried while maintaining its shape to obtain a thread-like molded product.

DNA/キトサン複合体のペレットを成型する型の図である。It is a figure of the type | mold which shape | molds the pellet of a DNA / chitosan complex. 成型したDNA/キトサン複合体のペレットを示す図である。It is a figure which shows the pellet of the shape | molded DNA / chitosan complex.

符号の説明Explanation of symbols

1 ステンレス板
2 シリコーン型
3 ナイロンメッシュ
4 型内に充填されたDNA/キトサン複合体
1 Stainless steel plate 2 Silicone mold 3 Nylon mesh 4 DNA / chitosan complex filled in mold

Claims (6)

DNA/キトサン複合体の成形方法において、
DNA/キトサン複合体を成型用の型内に充填する工程と、
前記型内に充填されたDNA/キトサン複合体に緩衝液を供給する工程と、
前記型内の前記緩衝液を含むDNA/キトサン複合体を該型内に充填した状態で凍結乾燥し、該型の形状に成型されたDNA/キトサン複合体成型物を得る工程と
を有することを特徴とするDNA/キトサン複合体の成形方法。
In a method for forming a DNA / chitosan complex,
Filling the DNA / chitosan complex into a mold for molding;
Supplying a buffer to the DNA / chitosan complex filled in the mold;
And lyophilizing the DNA / chitosan complex containing the buffer solution in the mold in a state of filling the mold to obtain a DNA / chitosan complex molded product molded into the shape of the mold. A method for forming a DNA / chitosan complex.
前記DNA/キトサン複合体が、水性媒体中でDNAとキトサンを反応させて沈殿物として得られたものである請求項1に記載の成形方法。   The molding method according to claim 1, wherein the DNA / chitosan complex is obtained as a precipitate by reacting DNA and chitosan in an aqueous medium. DNA/キトサン複合体の成形方法において、
DNA/キトサン複合体を緩衝液中に投与し、該DNA/キトサン複合体の塊を得る工程と、
前記該DNA/キトサン複合体の塊を成型用の型内に充填する工程と、
前記型内のDNA/キトサン複合体を該型内に充填した状態で凍結乾燥し、該型の形状に成型されたDNA/キトサン複合体成型物を得る工程と
を有することを特徴とするDNA/キトサン複合体の成形方法。
In a method for forming a DNA / chitosan complex,
Administering the DNA / chitosan complex in a buffer to obtain a mass of the DNA / chitosan complex;
Filling the DNA / chitosan complex mass into a mold for molding;
And a step of freeze-drying the DNA / chitosan complex in the mold in a state filled in the mold to obtain a DNA / chitosan complex molded product molded into the shape of the mold. A method for forming a chitosan composite.
前記DNA/キトサン複合体が、水性媒体中でDNAとキトサンを反応させて沈殿物として得られたものである請求項3に記載の成形方法。   4. The molding method according to claim 3, wherein the DNA / chitosan complex is obtained as a precipitate by reacting DNA and chitosan in an aqueous medium. DNA/キトサン複合体の成形方法において、
DNA/キトサン複合体の水性スラリーを緩衝液中に投与し、投入状態に応じた形状の固まりを得る工程と、
前記該DNA/キトサン複合体の塊を凍結乾燥し、前記投入状態に応じた形状のDNA/キトサン複合体成形物を得る工程と
を有することを特徴とするDNA/キトサン複合体の成形方法。
In a method for forming a DNA / chitosan complex,
Administering an aqueous slurry of DNA / chitosan complex into a buffer solution to obtain a mass of a shape according to the charged state;
And a step of freeze-drying the mass of the DNA / chitosan complex to obtain a DNA / chitosan complex molded product having a shape corresponding to the charged state.
前記DNA/キトサン複合体が、水性媒体中でDNAとキトサンを反応させて沈殿物として得られたものである請求項5に記載の成形方法。   The molding method according to claim 5, wherein the DNA / chitosan complex is obtained as a precipitate by reacting DNA and chitosan in an aqueous medium.
JP2005292630A 2005-10-05 2005-10-05 Method for forming DNA / chitosan complex Expired - Fee Related JP4354445B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005292630A JP4354445B2 (en) 2005-10-05 2005-10-05 Method for forming DNA / chitosan complex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005292630A JP4354445B2 (en) 2005-10-05 2005-10-05 Method for forming DNA / chitosan complex

Publications (2)

Publication Number Publication Date
JP2007097884A true JP2007097884A (en) 2007-04-19
JP4354445B2 JP4354445B2 (en) 2009-10-28

Family

ID=38025394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005292630A Expired - Fee Related JP4354445B2 (en) 2005-10-05 2005-10-05 Method for forming DNA / chitosan complex

Country Status (1)

Country Link
JP (1) JP4354445B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008110952A (en) * 2006-10-31 2008-05-15 Tadao Fukushima Method for producing film from complex of dna with polycation
WO2010071217A1 (en) 2008-12-19 2010-06-24 株式会社マルハニチロ食品 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
KR101710639B1 (en) * 2016-06-07 2017-03-08 주식회사 파마리서치프로덕트 Filler composition comprising nucleic acid, chitosan and hyaluronic acid for tissue augmentation and process for producing the same
CN109456503A (en) * 2017-09-06 2019-03-12 中国海洋大学 A kind of milt DNA/chitosan blend film and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6177335B2 (en) 2013-09-25 2017-08-09 マルハニチロ株式会社 Medical or dental material for bone formation

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008110952A (en) * 2006-10-31 2008-05-15 Tadao Fukushima Method for producing film from complex of dna with polycation
JP4718416B2 (en) * 2006-10-31 2011-07-06 忠男 福島 Method for producing a film from a complex of DNA and polycation
WO2010071217A1 (en) 2008-12-19 2010-06-24 株式会社マルハニチロ食品 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
JP2010163421A (en) * 2008-12-19 2010-07-29 Tadao Fukushima Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using the same
US9486496B2 (en) 2008-12-19 2016-11-08 Maruha Nichiro Corporation Anti periodontitis-causing microorganism agent and medical or dental materials using the same
KR101710639B1 (en) * 2016-06-07 2017-03-08 주식회사 파마리서치프로덕트 Filler composition comprising nucleic acid, chitosan and hyaluronic acid for tissue augmentation and process for producing the same
CN109195642A (en) * 2016-06-07 2019-01-11 医药研究产品有限公司 Tissue enhancing filled compositions comprising nucleic acid, chitosan and hyaluronic acid and preparation method thereof
CN109456503A (en) * 2017-09-06 2019-03-12 中国海洋大学 A kind of milt DNA/chitosan blend film and preparation method thereof
CN109456503B (en) * 2017-09-06 2021-06-25 中国海洋大学 Milt DNA/chitosan blend film and preparation method thereof

Also Published As

Publication number Publication date
JP4354445B2 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
Lim et al. Recent advances in supramolecular hydrogels for biomedical applications
Shi et al. pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy
Dong et al. Supramolecular hydrogels: synthesis, properties and their biomedical applications
Omar et al. Supramolecular hydrogels: Design strategies and contemporary biomedical applications
Luginbuhl et al. Recombinant synthesis of hybrid lipid–peptide polymer fusions that self‐assemble and encapsulate hydrophobic drugs
Phan et al. Polymerisation-induced self-assembly (PISA) as a straightforward formulation strategy for stimuli-responsive drug delivery systems and biomaterials: Recent advances
JP4354445B2 (en) Method for forming DNA / chitosan complex
Alcântara et al. Building up functional bionanocomposites from the assembly of clays and biopolymers
US7507764B2 (en) Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes
Fukui et al. Control in mineralization by the polysaccharide-coated liposome via the counter-diffusion of ions
Pérez-Pedroza et al. Supramolecular biopolymers for tissue engineering
Wang et al. Self-assembling peptides-based nano-cargos for targeted chemotherapy and immunotherapy of tumors: Recent developments, challenges, and future perspectives
Xu et al. Facile construction of nanofibers as a functional template for surface boron coordination reaction
Godoy-Gallardo et al. Nucleoside-based supramolecular hydrogels: From synthesis and structural properties to biomedical and tissue engineering applications
Li et al. Naturally occurring exopolysaccharide nanoparticles: formation process and their application in glutathione detection
JP2003518926A (en) Porous chitosan beads and method for producing the same
JP2010173976A (en) Pharmaceutical preparation and method for producing the same
JP4718416B2 (en) Method for producing a film from a complex of DNA and polycation
Chen et al. Recent Trends in the Development of Polyphosphazenes for Bio-applications
Lin et al. Nanoscale polyelectrolyte complex vesicles from bioinspired peptidomimetic homopolymers with zwitterionic property and extreme stability
KR101541604B1 (en) Method for preparing amylose bead by enzymatic synthesis
JP4665131B2 (en) POLYMER ELECTROLYTE COMPOSITE AND METHOD FOR PRODUCING THE SAME
JP2003261777A (en) Molecular complex formed under high pressure
Jayaraj et al. Microscopic studies on chitin and chitosan-based interpenetrating polymer networks, gels, blends, composites, and nanocomposites
JP2009171903A (en) Granular granulated substance and method for producing the same

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090708

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090729

R150 Certificate of patent or registration of utility model

Ref document number: 4354445

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120807

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120807

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130807

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees